Tumour regression following stem cell infusion from daughter to microchimeric mother

Lancet

Volumn 358, Issue 9298, 2001, Pages 2047-2048

  Tokita, Kenneth ^a   Terasaki, Paul ^b   Maruya, Etsuko ^c   Saji, Hiroh ^c  

^a Cancer Center of Irvine   (United States)

^b TERASAKI FOUNDATION LABORATORY   (United States)

^c Japanese Red Cross Kanto Koshinetsu Block Blood Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHIMERA; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FETUS CELL; HUMAN; INFUSION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; THYMUS CANCER; TREATMENT OUTCOME; TUMOR REGRESSION;

EID: 0035894607     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)07140-9     Document Type: Article

References (5)

1. Reinventing bone marrow transplantation: Reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancy
2. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis
3. Cell migration, chimerism, and graft acceptance
4. Reactivity of lymphocytes from normal persons on cultured tumor cells
5. Lymphocyte transfusion therapy for cancer patients